Efficacy, toxicity, and delivery methods of therapeutic ribonucleic acids (RNAs) for use in human immunodeficeincy virus (HIV) stem cell therapy

用于人类免疫缺陷病毒 (HIV) 干细胞治疗的治疗性核糖核酸 (RNA) 的功效、毒性和递送方法

• 批准号: 386550
• 负责人: Malard Camille
• 金额: $ 1.27万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-12-01 至 2018-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=386550&lang=en
• 关键词: Anti-Hiv Rnas; Cell Viability Assays; Flow Cytometry; Hiv Stem Cell Therapy; Hiv/Aids Cure; Lentiviral Delivery Systems; Molecular Cloning; Potency And Toxicity Screens; Screens For Immune Activation; Western Blots

According to the World Health Organization, HIV infects over 36 million individuals. Currently, antiretroviral therapies (ART) are available to control HIV replication and prevent disease progression, but cannot cure the infection. The use of stem cell th

根据世界卫生组织的数据，艾滋病毒感染者超过3600万人。目前，抗逆转录病毒疗法（ART）可用于控制艾滋病毒复制和预防疾病进展，但不能治愈感染。干细胞的应用